⌘K

Login Start Free

Home/Filings/4/0001415889-22-007078

4//SEC Filing

Walsh Angela 4

Accession 0001415889-22-007078

CIK 0001818844other

View on SEC.gov Company Profile

Filed

Jun 29, 8:00 PM ET

Accepted

Jun 30, 1:40 PM ET

Size

5.3 KB

Accession

0001415889-22-007078

Insider Transaction Report

Form 4

Period: 2022-06-23

Virios Therapeutics, Inc.VIRI

Chief Financial Officer

Transactions

Award
Stock Option (right to buy)
2022-06-23+40,000→ 40,000 total
Exercise: $4.23Exp: 2032-06-23→ Common Stock (40,000 underlying)

Footnotes (1)

[F1]The stock option vests one-third on June 23, 2023 and 1/24th monthly thereafter.

Documents

1 file

4
form4-06302022_100642.xmlPrimary

Issuer

Virios Therapeutics, Inc.

CIK 0001818844

Entity typeother

Related Parties

1

filerCIK 0001825987

Filing Metadata

Form type: 4
Filed: Jun 29, 8:00 PM ET
Accepted: Jun 30, 1:40 PM ET
Size: 5.3 KB

View on SEC.gov